iPC

Individualized Paediatric Cure: Cloud-based virtual-patient models for precision paediatric oncology

OFFICIAL WEBSITE

PROJECT TYPE

Horizon 2020

DURATION

01.01.2019 - 31.12.2022

PROJECT MANAGER AT XLAB

Jolanda Modic
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 826121.

Effective personalized medicine for paediatric cancers must address a multitude of challenges, including domain-specific ones. To overcome these challenges, the iPC project proposes a comprehensive computational effort to combine knowledge-base, machine-learning, and mechanistic models to predict optimal standard and experimental therapies for each child. Our approach is based on virtual patient models–in-silico avatars whose analysis can inform personalized diagnostics and recommend treatments. Our platform will also allow care givers to query models and infer benefits and drawbacks for specific treatment combinations for each child. To construct these models, we will combine state-of-the-art computational methods and data from molecular assays, and clinical and preclinical studies. We will test their predictions prospectively on data from clinical trials and test therapies in pre-clinical settings. We will focus on a select panel of paediatric tumours including both high-incidence and high-risk tumour types. To accomplish our goals, we have assembled an interdisciplinary team consisting of basic, translational, and clinical researchers – all amongst the leaders in their respective fields – and established strong relationships with European Centres of Excellence, patient organizations, and clinical trials focus on personalized medicine for our proposed case studies. We will produce, assemble, standardize, and harmonize accessible high-quality multi-disciplinary data and leverage the potential of Big Data and HPC for the personalized treatments of European citizens. We will make our models and data available through a cloud-based platform, whose exploitation will be maximised through a collaboration with the European Open Science Cloud initiative. In summary, iPC will address the critical need for personalized medicine for children with cancer, contribute to the digitalization of clinical workflows, and enable the Digital Single Market of the EU data infrastructure.

XLAB's role

XLAB will contribute to the development of the iPC platform and provide technical support in terms of cloud computing and security.
XLAB will contribute to the development of access control and anonymization mechanisms for different data sources, build a framework for communication between Data Access Committees and data providers/consumers, and build a cloud-based solution for computational models and securing data repositories.
Apart from the core technical work in the project, XLAB will also provide internal and external training activities for the use of the iPC platform and the utilization of computational models.